Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 44 Squamous Cell Carcinoma of Head and Neck 23 Carcinoma, Non-Small-Cell Lung 23 Head and Neck Neoplasms 13 Pancreatic Neoplasms 11 Neoplasm Metastasis 10 Carcinoma, Squamous Cell 8 Neoplasms 7 Lung Neoplasms 7 Colonic Neoplasms 7 Rectal Neoplasms 6 Esophageal Neoplasms 5 Carcinoma 5 Recurrence 4 Carcinoma, Renal Cell 4 Stomach Neoplasms 3 Neoplasms, Squamous Cell 3 Hereditary Sensory and Autonomic Neuropathies 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Colorectal Cancer Metastatic 3 Breast Neoplasms 3 Tongue Neoplasms 2 Sarcoma 2 Salivary Gland Neoplasms 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Melanoma 2 Glioma 2

Interventions

pembrolizumab 2 lenvatinib 1 abemaciclib 1 Tablets 1 Docetaxel 1 Combined Modality Therapy 1 Cetuximab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma, Adenoid Cystic × Cetuximab × Clear all

NCT01192087 2013-04-24

ACCEPT

Heidelberg University

Phase 1/2 Unknown

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡